Super excited for our research to get published. 20-50% of patients enrolled in hospice will get an antibiotic, and we have little understanding on the effects of these
Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management: A Scientific Statement From the American Heart Association | Circulation https://t.co/x5gB7OpKl7
❤️🔥 Congratulations Dan and colleagues. #AHA@MayoClinicINFD@MayoClinicCV
Presented at #ESCCongress:
Among adults with endocarditis caused by 𝘚. 𝘢𝘶𝘳𝘦𝘶𝘴, 𝘌. 𝘧𝘢𝘦𝘤𝘢𝘭𝘪𝘴, or streptococcus species, tailored-duration antibiotic therapy led to 13 more days alive without antibiotics than standard therapy, but with a higher incidence of relapse. Full POET II trial results: https://t.co/eiIXyt7k0K
@escardio
Welcome to our new incoming ID fellow class! We are so excited to have you in our training program! Best wishes! We are excited to see your growth in the coming years 😀
Our staff Dr Sohani presenting her oral abstract at ATC 2026
Having a CMV D+/R- mismatch status is associated with worse graft and patient survival at 7 years after lung transplantation.
Great work team!
Excellent work from our fellow Dr Policarpio and team describing P Vivax malaria in New York City. Great work team! Also an editors choice paper on OFID journal! https://t.co/PXmIiBzLyc
Trends in Long Duration Antibiotic Prescribing Following Focused Outpatient Antimicrobial Stewardship Efforts Across a Large Healthcare Enterprise
✅ Just Accepted
✍️ @InfectiousDan
🔗 https://t.co/d0REvoFFY2
Grateful for the opportunity to present our work at #ESCMIDGlobal2026@ESCMID exploring tetracycline susceptibility as a predictor of doxycycline activity in non-diphtheriae Corynebacterium 🦠 @MayoClinicINFD
📍 Munich, Germany 🇩🇪
Our fellows representing @MayoClinicINFD at ESCMID 2026. Here Dr Maamari presenting their group’s work on case series on abnormal vancomycin PK secondary to macrocomplexing. Great collaboration with our lab and ID pharmacy group!
Our fellows representing @MayoClinicINFD at ESCMID 2026. Here Dr Johnson presenting work on impact of PET-CT in patients with BSI and underlying CIED. Great work team!
Our fellows representing @MayoClinicINFD at ESCMID 2026. Here Dr Alvarez Mullet presenting work on a 10 year retrospective review of the creeping pattern of Daptomycin MIC in S. aureus. Another great collab with our microbiology and pharmacy colleagues!